Rating History for Sarepta Therapeutics (SRPT) by Barclays

More Stocks Rated by Barclays | Latest Ratings for SRPT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/25/2026 Eliana Merle Maintain Equalweight
(N/A)		 20.00
(N/A)		  
 		   Details